Lifetime health and economic consequences of obesity.

BACKGROUND Obesity is an established risk factor for several chronic diseases. The lifetime health and economic consequences of obesity for individual patients have not been documented. OBJECTIVE To estimate the lifetime health and economic consequences of obesity. METHODS We developed a dynamic model of the relationship between body mass index and the risks and associated costs of 5 obesity-related diseases: hypertension, hypercholesterolemia, type 2 diabetes mellitus, coronary heart disease, and stroke. The model was estimated using data from the Third National Health and Nutrition Examination Survey, the Framingham Heart Study, and other secondary sources. We used this model to estimate (1) risks of hypertension, hypercholesterolemia, and type 2 diabetes mellitus at future ages; (2) lifetime risks of coronary heart disease and stroke; (3) life expectancy; and (4) expected lifetime medical care costs of these 5 diseases for men and women aged 35 to 64 years with body mass indexes of 22.5, 27.5, 32.5, and 37.5 kg/m2 (nonobese and mildly, moderately, and severely obese, respectively). RESULTS Disease risks and costs increase substantially with increased body mass index. The risk of hypertension for moderately obese 45- to 54-year-old men, for example, is roughly 2-fold higher than for their nonobese peers (38.1% vs 17.7%), whereas the risk of type 2 diabetes mellitus is almost 3-fold higher (8.1% vs 3.0%). Lifetime risks of coronary heart disease and stroke are similarly elevated (41.8% vs 34.9% and 16.2% vs 13.9%, respectively), whereas life expectancy is reduced by 1 year (26.5 vs 27.5 years). Total discounted lifetime medical care costs for the treatment of these 5 diseases are estimated to differ by $10,000 ($29,600 vs $19,600). Similar results were obtained for women. CONCLUSIONS The lifetime health and economic consequences of obesity are substantial and suggest that efforts to prevent or reduce this problem might yield significant benefits.

[1]  G. Colditz,et al.  Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women , 1995, Annals of Internal Medicine.

[2]  G. Oster,et al.  The economic costs of smoking and benefits of quitting , 1985 .

[3]  D Spiegelman,et al.  Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. , 1995, American journal of epidemiology.

[4]  J. E. Lincoln,et al.  Actual causes of death in the United States. , 1994, JAMA.

[5]  G. Oster,et al.  Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practice. , 1996, Archives of internal medicine.

[6]  K. Flegal,et al.  Increasing Prevalence of Overweight Among US Adults: The National Health and Nutrition Examination Surveys, 1960 to 1991 , 1994 .

[7]  F. Pi‐Sunyer,et al.  Medical Hazards of Obesity , 1993, Annals of Internal Medicine.

[8]  M. Thun,et al.  The effect of age on the association between body-mass index and mortality. , 1998, The New England journal of medicine.

[9]  G. Oster,et al.  The economic costs of smoking and benefits of quitting for individual smokers. , 1984, Preventive medicine.

[10]  G A Colditz,et al.  The economic costs of non-insulin-dependent diabetes mellitus. , 1989, JAMA.

[11]  T. Hodgson,et al.  Cigarette smoking and lifetime medical expenditures. , 1992, The Milbank quarterly.

[12]  C. Swanson,et al.  Body weight: estimation of risk for breast and endometrial cancers. , 1996, The American journal of clinical nutrition.

[13]  W. O'Fallon,et al.  Survival and recurrence after first cerebral infarction , 1998, Neurology.

[14]  Graham A. Colditz,et al.  Body weight and mortality among women , 1995 .

[15]  J. Manson,et al.  Risk of symptomatic gallstones in women with severe obesity. , 1992, The American journal of clinical nutrition.

[16]  D. Felson,et al.  Obesity and knee osteoarthritis. The Framingham Study. , 1988, Annals of internal medicine.

[17]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine , 1997 .

[18]  G. Colditz,et al.  The cost of obesity: the US perspective. , 1994, PharmacoEconomics.

[19]  C. Swanson,et al.  Body weight: estimation of risk for breast and endometrial cancers. , 1996, The American journal of clinical nutrition.

[20]  G A Colditz,et al.  Current estimates of the economic cost of obesity in the United States. , 1998, Obesity research.

[21]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[22]  McGinnis Jm,et al.  Actual causes of death in the United States. , 1993 .

[23]  G. Oster,et al.  Cost‐effectiveness of Ticlopidine in Preventing Stroke in High‐risk Patients , 1994, Stroke.

[24]  Pi-Sunyer Fx.  Short-Term Medical Benefits and Adverse Effects of Weight Loss , 1993 .